Chemoprevention of Azoxymethane-induced Colonic Carcinogenesis by Supplemental Dietary Ursodeoxycholic Acid

Cancer Research

Volumn 54, Issue 19, 1994, Pages 5071-5074

  Roy, Hemant ^b   Khare, Sharad ^b   Brasitus, Thomas A ^b   Bissonette, Marc ^b   Wali, Ramesh K ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CHOLIC ACID; PIROXICAM; URSODEOXYCHOLIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; COLONIC NEOPLASMS; DIET; MALE; RATS; RATS, INBRED F344; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; URSODEOXYCHOLIC ACID;

EID: 0028072163     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. American Cancer Society. Cancer Facts and Figures. New York: American Cancer Society, 1986.
2. Jensen, O. M. MacLennen, R. and Wahrendorf, J. Diet, bowel function, fecal characteristics and large bowel cancer in Denmark and Finland. Nutr. Cancer, 4: 5-19, 1982.
3. Reddy, B. S. and Wynder, E. L. Metabolic epidemiology of colon cancer. Cancer (Phila.), 39: 2533-2539, 1981.
4. Stadler, J. Yeung, K. S. Furrer, R. Marcon, N. Himal, H. S. and Bruce, W. R. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett. 38: 315-320, 1988.
5. Moskovitz, M. White, C. Barnett, R. N. Stevens, S. Russell, E. Vargo, D. and Floch, M. H. Diet fecal bile acids, and neutral steroids in carcinoma of the colon. Dig. Dis. Sci. 24: 746-751, 1979.
6. Mudd, D. G. McKelvey, S. T. D. Norwood, W. Elmore, D. T. and Roy, A. D. Fecal bile acid concentrations of patients with carcinoma or increased risk of carcinoma in the large bowel. Gut, 21: 587-590, 1980.
7. Kalbara, N. Sasaki, T. Ikeguchi, M. Koga, S. and Ikawa, S. Fecal bile acids and neutral steroids in Japanese with large bowel carcinoma. Oncology, 40: 255-258, 1983.
8. Hikasa, Y. Tanida, N. Ohno, T. and Shimoyama, T. Fecal bile acid profiles in patients with large bowel cancer in Japan. Gut, 25: 833-838, 1984.
9. Tanida, N. Hikasa, Y. Shimoyama, T. and Setchell, K. D. R. Comparisons of fecal bile acid profiles between patients with adenomatous polyps of the large bowel and healthy subjects in Japan. Gut, 25: 824-832, 1984.
10. Ekbom, A. Yuen, J. Adami, H.-O. McLaughlin, J. K. Chow, W.-H. Persson, I. and Fraumeni, J. R. Jr. Cholecystectomy and colorectal cancer. Gastroenterology, 105: 142-147, 1993.
11. Gudmundson, S. Moller, T. R. and Olsson, H. Cancer incidence after cholecystectomy. A cohort study with 30 year follow up. Eur. J. Surg Oncol. 15: 113-117, 1989.
12. Nielsen, G. P. Theodore, A. Tulinus, and Sigualdson, H. Cholecystectomy and colorectal carcinoma: a total population historical prospective study. Am. J. Gastroenterol. 86: 1486-1490, 1991.
13. Hepner, G. W. Hofmann, A. F. Malagelada, J. R. Szczepanik, P. A. and Klein, P. D. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology, 66: 556-564, 1974.
14. Bayerdorffer, E. Mannes, G. A. Richter, W. O. Ochsenkuhn, T. Wiebecke, B. Kopeke, W. and Paumgartner, G. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology, 104: 145-151, 1993.
15. Wargovitch, M. J. Eng, V. W. S. Newmark, H. L. and Bruce, W. R. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis (Lond.), 4: 1205-1207, 1983.
16. Bull, A. W. Marnett, L. J. Dawe, E. J. and Nigro, N. D. Stimulation of deoxythy-midine incorporation in the colon of rats treated intrarectally with bile acids and fats. Carcinogenesis (Lond.), 4: 207-210, 1983.
17. Skraastad, O. and Reichelt, K. L. An endogenous colon mitosis inhibitor and dietary calcium inhibit the increased colonic cell proliferation by cholic acid. Scand. J. Gastroenterol. 23: 801-807, 1988.
18. Lapre, J. A. and Vander der Meer, R. Diet-induced increase of colonic bile acids stimulates lytic activity of fecal water and proliferation of colon cells. Carcinogenesis (Lond.), 13: 41-44, 1992.
19. Deschner, E. E. Cohen, B. I. and Raicht, R. F. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion, 21: 290-296, 1981.
20. Bird, R. P. Schneider, R. Stamp, D. and Bruce, W. R. Effect of dietary calcium and cholic acid on the proliferative indices of murine colonic epithelium. Carcinogenesis (Lond.), 7: 1657-1661, 1986.
21. Maskens, A. P. and Deschner, E. E. Tritiated thymidine incorporation into epithelial cells of normal appearing colorectal mucosa of cancer patients. J. Natl. Cancer Inst. 58: 1221-1224, 1977.
22. Terpstra, O. T. Van Blankenship, M. Dees, J. and Eilers, G. A. M. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology, 92: 704-708, 1987.
23. Rosio, M. Lipkin, M. Candelares, G. L. Bertone, A. Coverlizza, S. and Rossini, F. P. Correlation between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res. 51: 1917-1921, 1991.
24. Preston-Martin, S. Pike, M. C. Ross, R. K. Jones, P. A. and Henderson, B. E. Increased cell division in a human cancer. Cancer Res. 50: 7415-7421, 1990.
25. Kuniyasu, T. Tanaka, T. and Oshima, T. Enhancing effect of cholecystectomy on colon carcinogenesis induced by methylazoxymethanol in hamsters. Dis. Colon Rectum, 29: 492-494, 1986.
26. Koga, S. Kaibara, N. and Takida, R. Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer (Phila.), 50: 543-547, 1982.
27. McSheery, C. K. Cohen, B. I. Bokkenheuser, V. D. Mosbach, E. H. Winter, J. Matoba, N. and Scholes, J. Effect of calcium and bile acid feeding on colon tumors in the rat. Cancer Res. 49: 6039-6043, 1989.
28. Reddy, B. S. Watanabe, K. Weisburger, J. H. and Wynder, E. L. Promoting effects of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 37: 3238-3242, 1977.
29. Koga, Y. Anti-cholestatic and cytoprotective properties of ursodeoxycholic acid. Studies in vivo and in vitro. Acta Herpatol. Jpn. 28: 1597-1604, 1987.
30. Leuschner, U. Fischer, H. Kurtz, W. Guldutuna, S. Hubner, K. Hellstem, A. Gatzen, M. and Leuschner, M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double blind trial. Gastroenterology, 97: 1268-1274, 1989.
31. White, B. A. Fricke, R. J. and Hylemon, P. B. 70-dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. J. Lipid Res. 23: 145-153, 1982.
32. Chadwick, V. S. Gaginella, T. S. Carlson, G. L. Debongnie, J.-C. Phillips, S. F. and Hofmann, A. F. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rat colon. J. Lab. Clin. Invest. 94: 661-674, 1979.
33. Czygan, P. Seitz, H. Waldherr, R. Stiehr, A. Raedsch, R. and Kommerell, B. Chenodeoxycholic acid but not ursodeoxycholic acid enhances colonic carcinogenesis in the rat. In: G. Paumgartner (ed.), Bile Acid and Cholesterol in Health and Disease, 22: pp. 383-385, 1984.
34. Reddy, B. Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of colon tumor development. Cancer Res. 47: 5340-5346, 1987.
35. Reddy, B. S. Nayini, J. Tokumo, K. Rigotty, J. Zang, E. and Kelloff, G. Chemo-prevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D, L-a-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50: 2562-2568, 1990.
36. Brasitus, T. A. Dudeja, P. K. and Dahiya, R. Premalignant alterations in the lipid composition and fluidity of colonic brush-border membranes of rats administered 1,2-dimethylthydrazine. J. Clin. Invest. 77: 831-840, 1986.
37. Snedecor, G. W. and Cochran, W. G. Statistical Methods, Ed. 7. Ames, IA: Iowa State University Press, 1980.
38. Earnest, D. L. Hixson, L. J. Fennerty, M. B. Emerson, S. S. and Alberts, D. S. Inhibition of prostaglandin synthesis potential for chemoprevention of human cancer. Cancer Bull. (Houst.), 43: 561-568, 1991.
39. Wargovich, M. J. Dietary promoters and antipromoters. In: D. M. Shankel, P. E. Hartman, T. Kaba, and A. Hollaender, (eds.), Antimutagenesis and Anticarcinogen-esis Mechanisms, pp. 409-420, New York: Plenum Publishing Corp. 1986.
40. Cohen, B. I. Raicht, R. F. Deschner, E. E. Takahashi, M. Sarwal, A.N. and Fazzini, E. Effect of cholic acid feeding on jV-methyl-jV-nitrosourea-induced colon tumors and cell kinetics in rats. J. Natl. Cancer Inst. 64: 573-578, 1980.
41. Kurtz, W. J. O. Guldutuna, S. and Leuschner, U. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid or bile acids in rat colonic wall and contents. Tokai J. Exp. Clin. Med. 13: 91-97, 1988.
42. Bazzoli, F. Fromm, H. Sarva, R. D. Sembrat, R. F. and Ceryak, S. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in man. Gastroenterology, 83: 753-760, 1982.